Literature DB >> 21439418

Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.

Wei Zhang1, Steven D Rhodes, Liming Zhao, Yongzheng He, Yingze Zhang, Yong Shen, Dalong Yang, Xiaohua Wu, Xiaohong Li, Xianlin Yang, Su-Jung Park, Shi Chen, Charles Turner, Feng-Chun Yang.   

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder caused by mutation of the NF1 tumor suppressor gene. Spinal deformities are common skeletal manifestations in patients with NF1. To date, the mechanism of vertebral abnormalities remains unclear because of the lack of appropriate animal models for the skeletal manifestations of NF1. In the present study, we report a novel murine NF1 model, Nf1(flox/-);Col2.3Cre(+) mice. These mice display short vertebral segments. In addition, a significant reduction in cortical and trabecular bone mass of the vertebrae was observed in Nf1(flox/-);Col2.3Cre(+) mice as measured by dual-energy X-ray absorptiometry (DEXA) and peripheral quantitative computed tomography (pQCT). Peak stress and peak load were also significantly reduced in Nf1(flox/-);Col2.3Cre(+) mice as compared to controls. Furthermore, the lumbar vertebrae showed enlargement of the inter-vertebral canal, a characteristic feature of lumbar vertebrae in NF1 patients. Finally, histologic analysis demonstrated increased numbers of osteoclasts and decreased numbers of osteoblasts in the vertebrae of Nf1(flox/-);Col2.3Cre(+) mice in comparison to controls. In summary, Nf1(flox/-);Col2.3Cre(+) mice demonstrate multiple structural and functional abnormalities in the lumbar vertebrae which recapitulate the dystrophic vertebral changes in NF1 patients. This novel murine model provides a platform to understand the cellular and molecular mechanisms underlying the pathogenesis of spinal deficits in NF1 patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21439418      PMCID: PMC3584682          DOI: 10.1016/j.bone.2011.03.760

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  60 in total

1.  Bipedal rats and mice; laboratory animals for orthopaedic research.

Authors:  C W GOFF; W LANDMESSER
Journal:  J Bone Joint Surg Am       Date:  1957-06       Impact factor: 5.284

2.  Cervical Spine Research Society Presidential Address: a 25-year correlation with history.

Authors:  S R Garfin
Journal:  Spine (Phila Pa 1976)       Date:  1997-11-15       Impact factor: 3.468

3.  Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.

Authors:  M Milne; M I Kang; J M Quail; D T Baran
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

4.  Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.

Authors:  X Yu; S Chen; O L Potter; S M Murthy; J Li; J M Pulcini; N Ohashi; T Winata; E T Everett; D Ingram; W D Clapp; J M Hock
Journal:  Bone       Date:  2005-03-29       Impact factor: 4.398

5.  The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.

Authors:  R P Atit; M J Crowe; D G Greenhalgh; R J Wenstrup; N Ratner
Journal:  J Invest Dermatol       Date:  1999-06       Impact factor: 8.551

6.  Progesterone- and dexamethasone-dependent osteoprogenitors in bone cell populations derived from rat vertebrae are different and distinct.

Authors:  Y Ishida; J N Heersche
Journal:  Endocrinology       Date:  1999-07       Impact factor: 4.736

7.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

8.  The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.

Authors:  M N Ajuebor; C M Hogaboam; S L Kunkel; A E Proudfoot; J L Wallace
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Whole-spine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity.

Authors:  Manoj Ramachandran; Athanasios I Tsirikos; Joshua Lee; Asif Saifuddin
Journal:  J Spinal Disord Tech       Date:  2004-12

10.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.

Authors:  T Jacks; T S Shih; E M Schmitt; R T Bronson; A Bernards; R A Weinberg
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

View more
  10 in total

1.  Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.

Authors:  Hsiao-Fang Wang; Yu-Tzu Shih; Chiung-Ya Chen; Hsu-Wen Chao; Ming-Jen Lee; Yi-Ping Hsueh
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

2.  Height assessments in children with neurofibromatosis type 1.

Authors:  Elizabeth A Soucy; Dorothy van Oppen; Nicole L Nejedly; Feng Gao; David H Gutmann; Abby S Hollander
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

Review 3.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

4.  Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Authors:  Steven D Rhodes; Xiaohua Wu; Yongzheng He; Shi Chen; Hao Yang; Karl W Staser; Jiapeng Wang; Ping Zhang; Chang Jiang; Hiroki Yokota; Ruizhi Dong; Xianghong Peng; Xianlin Yang; Sreemala Murthy; Mohamad Azhar; Khalid S Mohammad; Mingjiang Xu; Theresa A Guise; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

5.  c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.

Authors:  Yongzheng He; Steven D Rhodes; Shi Chen; Xiaohua Wu; Jin Yuan; Xianlin Yang; Li Jiang; Xianqi Li; Naoyuki Takahashi; Mingjiang Xu; Khalid S Mohammad; Theresa A Guise; Feng-Chun Yang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.

Authors:  Xiaohua Wu; Shi Chen; Yongzheng He; Steven D Rhodes; Khalid S Mohammad; Xiaohong Li; Xianlin Yang; Li Jiang; Grzegorz Nalepa; Paige Snider; Alexander G Robling; D Wade Clapp; Simon J Conway; Theresa A Guise; Feng-Chun Yang
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

7.  Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.

Authors:  Shuang Yang; Hong Liu; Lei Zhu; Xinle Li; Daquan Liu; Xiaomeng Song; Hiroki Yokota; Ping Zhang
Journal:  FASEB J       Date:  2019-07-02       Impact factor: 5.834

Review 8.  RASopathies: unraveling mechanisms with animal models.

Authors:  Granton A Jindal; Yogesh Goyal; Rebecca D Burdine; Katherine A Rauen; Stanislav Y Shvartsman
Journal:  Dis Model Mech       Date:  2015-08-01       Impact factor: 5.758

9.  Dystrophic spinal deformities in a neurofibromatosis type 1 murine model.

Authors:  Steven D Rhodes; Wei Zhang; Dalong Yang; Hao Yang; Shi Chen; Xiaohua Wu; Xiaohong Li; Xianlin Yang; Khalid S Mohammad; Theresa A Guise; Amanda L Bergner; David A Stevenson; Feng-Chun Yang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

Review 10.  The involvement of endoplasmic reticulum formation and protein synthesis efficiency in VCP- and ATL1-related neurological disorders.

Authors:  Yu-Tzu Shih; Yi-Ping Hsueh
Journal:  J Biomed Sci       Date:  2018-01-08       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.